PGH
RPRX icon

Partners Group Holding’s Royalty Pharma RPRX Stock Holding History

Partners Group Holding’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86M Buy
157,944
+70,879
+81% +$3.69M 0.6% 32
2026
Q1 		$4.18M Buy
87,065
+37,210
+75% +$1.63M 0.31% 34
2025
Q4 		$1.93M Buy
+49,855
New +$1.9M 0.13% 35

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Partners Group Holding's RPRX Position: Q2 2026 in Review

Partners Group Holding increased its Royalty Pharma (RPRX) stake by 81% in Q2 2026, buying an estimated $3.69M and bringing the position to 157,944 shares worth $8.86M. The position accounts for 0.6% of the portfolio, ranked #32.

Partners Group Holding first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Partners Group Holding held 157,944 shares of Royalty Pharma worth $8.86M as of Q2 2026.
  • Partners Group Holding bought 70,879 Royalty Pharma shares in Q2 2026, an estimated $3.69M.
  • Royalty Pharma made up 0.6% of Partners Group Holding's portfolio in Q2 2026, its #32 holding.
  • Partners Group Holding first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Partners Group Holding's 13F filing for Q2 2026, filed 4 Aug 2026.